BRKR - Bruker Corporation
Handelsbanken Fonder AB increased its holdings in Bruker Corporation (NASDAQ: BRKR) by 49.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,805 shares of the medical research company's stock after acquiring an additional 18,165 shares during the period. Handelsbanken Fonder
Bank of America Corp DE cut its holdings in shares of Bruker Corporation (NASDAQ: BRKR) by 3.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 933,596 shares of the medical research company's stock after selling 30,371 shares during the quarter.
BOSTON--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary. Financial details were not disclosed. Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY sc.
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced huma
LEIDEN, The Netherlands--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker's post-genomic solutions for disease biology research, as well as for drug discovery and development into Microphysiological Systems (MPS), also referred to as New Approach Methodologies (NAMs), and based on human ph.
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
The Dow is up over 800 points after Monday's rally while upbeat earnings from Palantir (PLTR) is lifting tech and the broader market
The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Bruker NASDAQ: BRKR reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research.
Bruker (BRKR) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.32 per share a year ago.
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026.Frank H. Laukien, Bruker's Pre
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026. Frank H. Laukien, Bruker's President and CEO, commented: “We returned to organic revenue growth in the second quarter and our Scientific Instruments segment achieved 10% organic bookings growth year-over-year. Our focus on cost and profitability resulted in solid margin expansion and non-GAAP EPS growth in the quarter. In particular, we achieve.
Dimensional Fund Advisors LP grew its position in Bruker Corporation (NASDAQ: BRKR) by 23.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,341,518 shares of the medical research company's stock after acquiring an additional 448,440 shares during the
On July 28, 2026, Bruker Corp (BRKR) shares rose by 4.8% to a current price of $62.91, reflecting positive momentum in the stock. Over the past year, the shares
Bank of New York Mellon Corp lessened its position in shares of Bruker Corporation (NASDAQ: BRKR) by 6.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 780,955 shares of the medical research company's stock after selling 55,379 shares during the period.
First Trust Advisors LP increased its position in shares of Bruker Corporation (NASDAQ: BRKR) by 32.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,493,053 shares of the medical research company's stock after acquiring an additional 366,187 shares during the
California Public Employees Retirement System trimmed its position in Bruker Corporation (NASDAQ: BRKR) by 27.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,653 shares of the medical research company's stock after selling 51,544 shares during the quarter. California
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026. The Company will host a conference call and webcast at 9:00 a.m. Eastern Daylight Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q2 2026 Earnings Webcast” hyperlink in the “Events & Presentations” section. A sli.
On July 23, 2026, Bruker Corp (BRKR) shares rose 4.0% today, bringing the current price to $62.15. The stock has shown a strong performance over the last year,
Fifth Third Bancorp boosted its holdings in Bruker Corporation (NASDAQ: BRKR) by 4,058.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,135 shares of the medical research company's stock after purchasing an additional 55,761 shares during the